A. SARI Et Al. , "The use of rituximab in patients with rheumatoid arthritis: in which infusion intervals were given and how did they respond? HUR-BIO real life results," EULAR- Annual European Congress of Rheumatology, 2017 , Spain, 2017
SARI, A. Et Al. 2017. The use of rituximab in patients with rheumatoid arthritis: in which infusion intervals were given and how did they respond? HUR-BIO real life results. EULAR- Annual European Congress of Rheumatology, 2017 , (Spain).
SARI, A., GÜVEN, D. C., ARMAĞAN, B., KILIÇ, L., ERDEN, A., & AKDOĞAN, A., (2017). The use of rituximab in patients with rheumatoid arthritis: in which infusion intervals were given and how did they respond? HUR-BIO real life results . EULAR- Annual European Congress of Rheumatology, 2017, Spain
SARI, ALPER Et Al. "The use of rituximab in patients with rheumatoid arthritis: in which infusion intervals were given and how did they respond? HUR-BIO real life results," EULAR- Annual European Congress of Rheumatology, 2017, Spain, 2017
SARI, ALPER Et Al. "The use of rituximab in patients with rheumatoid arthritis: in which infusion intervals were given and how did they respond? HUR-BIO real life results." EULAR- Annual European Congress of Rheumatology, 2017 , Spain, 2017
SARI, A. Et Al. (2017) . "The use of rituximab in patients with rheumatoid arthritis: in which infusion intervals were given and how did they respond? HUR-BIO real life results." EULAR- Annual European Congress of Rheumatology, 2017 , Spain.
@conferencepaper{conferencepaper, author={ALPER SARI Et Al. }, title={The use of rituximab in patients with rheumatoid arthritis: in which infusion intervals were given and how did they respond? HUR-BIO real life results}, congress name={EULAR- Annual European Congress of Rheumatology, 2017}, city={}, country={Spain}, year={2017}}